Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Thrombocytopenia 1Neutropenia 1Neoplasms 1Genital Neoplasms, Female 1Colorectal Neoplasms 1Breast Neoplasms 1Anemia 1

Interventions

Filgrastim 6pegylated granulocyte colony-stimulating factor 4pegfilgrastim 4Vancomycin 3Etoposide 3Cytarabine 3Cefepime 3Amikacin 3Teicoplanin 2Methotrexate 2Meropenem 2Granulocyte Colony-Stimulating Factor 2Daunorubicin 2Cyclosporine 2Ciprofloxacin 2Ceftazidime 2ziprasidone 1niraparib 1lintuzumab 1leridistim 1fludarabine phosphate 1angiotensin I (1-7) 1Zolpidem 1Warfarin 1Vitamin B 12 1Vincristine 1Vecuronium Bromide 1Transplantation 1Tranexamic Acid 1Tobramycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × Moxibustion × Classical hematology × Clear all
NCT02781155 2016-05-24

Limiting Chemotherapy Side Effects by Using Moxa

East and North Hertfordshire NHS Trust

Phase 1/2 Unknown
25 enrolled
BreastClassical hematologyGastrointestinal

Anemia, Breast Neoplasms, Genital Neoplasms, Female, Neoplasms, Neutropenia, Thrombocytopenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡